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Background: Intellectual disability (ID) and dementia reflect disturbed cortical
function during and after developmental age, respectively. Due to the wide hetero-
geneity of ID population the decline in cognitive and adaptive skills may be dif-
ferent in distinct genetic subgroups.
Methods: Using the British Present Psychiatric State–learning Disabilities assess-
ment (PPS‐LD) questionnaire the dementia signs were screened in 62, 22 and 44
individuals (> 35 year of age) with Down (DS, OMIM number 190685), Williams
(WS, OMIM number, 194050), and Fragile X syndrome (FXS, OMIM number
309550), respectively. The median age of those with FXS (59 years) was higher
than of those with DS (50 years) and WS (53 years).
Results: Most study participants with DS (80%) and FXS (89%) were or had
been moderately or severely intellectually disabled while most participants with
WS (73%) were or had been mildly or moderately disabled at adolescent age. The
adolescent (premorbid) level of ID did not correlate with the dementia score. The
median scores were 11/27, 1/27, and 0/27 in DS, WS, and FXS subgroups,
respectively. Dementia that was confirmed by brain imaging, manifested as Alz-
heimer disease and as moya‐moya disease associated vascular dementia in DS and
as vascular dementia in WS.
Conclusions: This survey suggests that the risk of dementia varies depending on
the cause of ID and that the severity of ID in adolescence does not predict the
development of dementia at a later age. Consequently, the ID and dementia
should be understood as separate clinical entities that need to be taken into
account in the health management of intellectually disabled people. This is impor-
tant for the arrangement of appropriate and timely interventions, which can be
expected to delay the need for institutionalization.
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1 | INTRODUCTION
Intellectual disability (ID) and dementia reflect disturbed
cortical function during developmental age and after devel-
opmental age, respectively. Alzheimer disease (AD) and
vascular dementia are the most common dementia syn-
dromes, both of which have a multifactorial etiology.
Down syndrome represents the most common genetic, cere-
bral palsy‐ID the most common acquired, and autism spec-
trum‐ID the most common multi‐factorial ID syndrome.
However, these three most common entities represent only
40%–55% of all people with IDs the remaining 45%–60%
represent numerous smaller entities (Arvio & Sillanpää,
2003). In other words, intellectually disabled persons form
an extremely heterogeneous population with different neu-
ropsychiatric and somatic characteristics depending on the
etiology of ID. Consequently, evaluation of dementia syn-
dromes separately in different etiological ID subgroups can
be considered clinically meaningful.
Intellectual disability itself bears many risk factors for
cognitive impairment and dementia. Firstly, apart from
disturbed cortical function, ID often associates with a
structural cortical damage or dysgenesis. Secondly, nutri-
tional factors form a double‐edged sword; overweight is
common in certain genetic ID syndromes as is malnutri-
tion resulting from swallowing difficulties or spasticity in
some acquired ID syndromes. Thirdly, many persons
with ID, especially those with autism spectrum disorders
need polypharmacy because of their aggressive behaviors
and other neuropsychiatric disorders and, thus, they may
suffer from drug induced cognitive impairment. Finally,
persons with ID may have a weak physical fitness sim-
ply because they cannot attend healthy cultural and sport
activities without sufficient support and assistance from
other people.
The national health care routines in Finland include eti-
ological and neuropsychological evaluations that are done
when a cognitive developmental delay is observed in chil-
dren or when dementia is suspected in adults. Further, a
licenced psychologist checks routinely the level of ID when
an intellectually disabled person graduates, because such a
statement from such an evaluation is needed for postgradu-
ate studies and for disability allowance, which is financed
by KELA (Social Insurance Institution of Finland). In
accordance, the social security covers medicine costs only
when the diagnosis of Alzheimer's disease has been con-
firmed by a brain magnetic resonance image or a computer
tomography. Because of compliance problems, a brain
imaging may not always be possible without sedation for
patients with ID. Therefore, it is usually performed only in
those cases when a cerebrovascular disorder or epilepsy is
suspected in order to avoid risks related to anesthesia.
This study is a part of a larger project evaluating aging
in the three most common genetic syndromes, that is,
Down (DS, OMIM #190685), Williams (WS, OMIM
#194050) and Fragile X (FXS, OMIM #309550), syn-
dromes. DS (caused by trisomy 21) and WS (caused by
hemizygosity at chromosomal site 7q11.23) affect equally
both genders while FXS (caused by a mutation in the
FMR1 gene located on the long arm of the X chromosome)
affects mainly males. Those with DS and WS represent
10%–15% and approximately 0.5% of intellectually dis-
abled population, respectively, and males with FXS repre-
sent approximately 2% of all males with an ID (Arvio &
Sillanpää, 2003). Many study subjects of this study have
participated in our earlier prospective follow‐up and other
studies (Arvio, 2016; Arvio & Bjelogrlic‐Laakso, 2017;
Arvio & Luostarinen, 2016; Arvio, Peippo, & Simola,
1997; Eronen et al., 2002). For the present study, we
recruited new individuals in order to compare the signs of
dementia between these three genetic ID syndromes.
2 | PATIENTS AND METHODS
2.1 | Ethical compliance
The study was approved and reviewed by Pirkanmaa
University Hospital District's ethics committee and a writ-
ten informed consent was received from each participant or
from their caretaker.
Finland is divided into 16 state‐supported regional full‐
service districts for individuals who have ID. The authors
(i.e., a neuropsychologist, 1st author and three neurolo-
gists), employees in different district organizations,
assessed the study subjects and analyzed their medical
records including data of brain scanning and the adolescent
level of ID. For this study, all individuals (>35 years of
age) with DS, WS, and FXS living in the South‐Häme dis-
trict and all individuals with WS and FXS living in Pirkan-
maa, Northern Ostrobothnia, and Southwest Finland
districts were invited to participate. All 62 participants with
DS, four of 22 with WS, and 19 of the 44 with FXS, have
been included in our earlier studies (Arvio, 2016; Arvio &
Bjelogrlic‐Laakso, 2017; Arvio & Luostarinen, 2016; Arvio
et al., 1997; Eronen et al., 2002).
The British Present Psychiatric State‐Learning Disabili-
ties assessment (PPS‐LD) was used for the screening of
dementia signs. This PPS‐LD questionnaire includes 27
items and has been used in Finland as a tool in the dementia
diagnostics, particularly among people who have ID (Arvio,
2016; Arvio, Ajasto, Koskinen, & Louhiala, 2013; Arvio &
Bjelogrlic‐Laakso, 2017; Cooper, 1997a,b; Mölsä, 2001).
The relationship between the number of dementia signs
(i.e., dementia score) and the chronological age was
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estimated by using regression models with the quadratic
term of age. Bootstrap estimation was used to derive a
95% confidence interval of curvilinear correlation.
3 | RESULTS
Clinical data of the three subgroups are presented in
Table 1. The median age of those with FXS (59 years) was
higher than of those with DS (50 years) and WS
(53 years). Most study subjects with DS (80%) and FXS
(89%) were or had been moderately or severely intellectu-
ally disabled while most individuals with WS (73%) were
or had been mildly or moderately disabled at adolescent
age (Table 1).
Figure 1 shows dementia scores according to chronolog-
ical age and Table 2 the division of 27 dementia signs in
the three etiological subgroups. Those with DS had the
highest scores (median score 11); reduced self‐care skills,
loss of energy, impaired understanding, and forgetfulness
were their most common signs (Table 2). In WS subjects
(median score 1), the most common signs included weight
change, change in appetite, onset or increase of physical
aggression and reduced quantity of speech. Those with
FXS, had the lowest dementia scores (median score 0).
Table 3 presents the state of health of the subjects. All
subjects with WS had co‐morbidities of which the most
commonly occurring were hypertension, psychiatric disor-
der, hypercholesterolemia and congenital heart defect.
Dementia was diagnosed in each case by typical symptoms
and by brain imaging. In DS, it manifested as Alzheimer
disease in all but one subject who had vascular dementia
(presumably resulting from moyamoya disease and cerebral
hemorrhage) and as vascular dementia in subjects with WS
(presumably evolving from transient ischemic attacks). In
addition, the neurologist in charge had prescribed acetyl-
cholinesterase inhibitor or memantine to 14 other subjects
with DS with without brain scanning, after excluding other
disorders that may mimic dementia.
There was no connection between the adolescent (pre-
morbid) severity of ID and dementia score (Table 4). The
most common dementia signs among the three subjects
(ages 50, 53, and 61 year) with a profound ID (as esti-
mated at adolescence) were weight change, loss of energy
and sleep disorder. The most common dementia signs of
the four youngest DS subjects (ages 39, 42, 42, and
43 year) with mild ID (as estimated at adolescence) were
irritability, worry, weight change, and reduced self‐help
skills.
4 | DISCUSSION
The centralized service system for intellectually disabled
persons, since the 1960's, has made the scientific research
TABLE 1 Clinical data of the study subgroups
Down Williams Fragile X




Severity of ID at adolescence
Subnormal 0 1 (4.5%) 1 (2%)
Mild 11 (17.5%) 13 (59%) 3 (7%)
Moderate 26 (43%) 3 (14%) 17 (39%)
Severe 24 (37%) 4 (18%) 22 (50%)
Profound 1 (2.5%) 1 (4.5%) 1 (2%)
Note. ID: intellectual disability.
Age, years


















35 40 45 50 55 60 65 70 75 80 85
Williams syndrome
Age, years
35 40 45 50 55 60 65 70 75 80 85
Fragile X syndrome
r=0.63 (95% CI: 0.45 to 0.76)
r=0.41 (95% CI: 0.11 to 0.64) r=0.52 (95% CI: 0.13 to 0.77)
FIGURE 1 Dementia scores of three etiological subgroups according chronological age
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of ID medicine possible in Finland. During the past dec-
ades the life expectancy of intellectually disabled persons
has increased (Arvio, Salokivi, & Bjelogrlic‐Laakso, 2016;
Arvio, Salokivi, Tiitinen, & Haataja, 2016; Westerinen et
al., 2016). According to our national registries, 8% of per-
sons with ID are nowadays senior citizens (aged 65+)
while the respective percentage 20 years ago was 2%
(Arvio, Salokivi, & Bjelogrlic‐Laakso, 2016). Still, there
are not many DS persons aged over 65 as seen also in this
survey, whereas one‐third of our WS subjects and one‐
fourth of our FXS subjects were senior citizens (Figure 1).
The same British questionnaire (as used in Finland since
early 2000, 7–10) has been used as a measurement tool in
all these assessments, which allows a reliable comparison
of the occurrence of dementia signs in different ID
syndromes.
Intellectually disabled persons form both etiologically
and clinically an extremely heterogeneous group of people
and the results of this study indicate that the etiology of ID
has a significant prognostic role in the development of neu-
rodegenerative dementia. The association between DS and
Alzheimer disease has been known for a long time (Even-
huis, 1990, 1996; Golden, Nielsen, Pober, & Hyman, 1995;
Head, Powell, Gold, & Schmitt, 2012; McCarron et al.,
2017; Tyrrell et al., 2001) and as expected, the persons
with DS were found to have the highest dementia scores.
There is an earlier case report of a young WS patient
showing neuropathological findings resembling Alzheimer
disease (Shultz et al., 2004); but in this study three elderly
WS subjects, not unexpectedly (with a history of transient
ischemic attacks) suffered from vascular dementia. Almost
no dementia signs were observed in FXS subjects although
their median age was 9 years higher than that of the DS
subjects. Thus, it seems reasonable to assume that the
dementia development should be followed more carefully
in DS and WS than in FXS so that the early signs of
dementia are recognized in time in order to initiate appro-
priate interventions and, thus, to prevent a premature
institutionalization.
On the other hand, the severity of ID (determined in
adolescence) did not seem to predict the development of
dementia at later age. In this study, the signs of dementia
were found to be somewhat different in mild and profound
ID. In the three subjects with profound ID, the most com-
mon dementia signs were weight change, loss of energy,
sleep disorder, whereas among the four youngest patients
with mild ID, the leading symptoms were irritability,
worry, weight change, and reduced self‐help skills.
The results from earlier studies on dementia in intellec-
tually disabled persons published by others cannot be com-
pared directly with our results because of different study
designs and different patient characteristics. For example,
in the papers of Evenhuis and Shutz et al. (Evenhuis, 1990,
1996; Golden et al., 1995) the adolescence level of ID has
not been defined and it has not been detailed how the study
participants had been divided into demented and nonde-
mented at the base line. Another confounding factor is
related to grouping study participants to DS and non‐DS
patients without defining the etiology of the latter group,
which may represent numerous genetic, acquired and mul-
ti‐factorial entities and even progressive disorders. Taken
the heterogeneity of ID population, no reliable conclusions
on the risk and the onset age of dementia can be drawn
without the known etiology of ID and without the deter-
mined best level of ID, which is usually reached at young
adulthood.




Autonomic anxiety 16 (25%) 1 (5%) 1 (2%)
Change in appetite 8 (12.5%) 3 (14%) 1 (2%)
Changed sleep pattern 21 (35%) 2 (9%) 1 (2%)
Coarsening of personality 16 (25%) 1 (5%) 1 (2%)
Confusion 8 (12.5%) 0 0
Delusions 6 (10%) 1 (5%) 0
Diurnal mood variation 14 (22.5%) 1 (5%) 1 (2%)
Forgetful 28 (45%) 0 1 (2%)
Forgetting people′s names 5 (7.5%) 2 (9%) 0
Geographical disorientation 9 (15%) 0 0
Impaired understanding 34 (55%) 1 (5%) 1 (2%)
Irritability 19 (30% 2 (9%) 1 (2%)
Loss of concentration 21 (35%) 0 0
Loss of energy 37 (60%) 2 (9%) 1 (2%)
Loss of literacy skills 6 (10%) 1 (5%) 1 (2%)
Misery 16 (25%) 0 0
Onset of or increase
In other maladaptive
behavior
11 (17.5%) 1 (5%) 0
In physical aggression 11 (17.5%) 3 (14%) 1 (2%)
In verbal aggression 6 (10%) 1 (5%) 0
Of fearfulness 16 (25%) 1 (5%) 1 (2%)
Reduced quantity of speech 26 (42.5%) 3 (14%) 0
Reduced self‐care skills 40 (63.5%) 2 (9%) 1
Social withdrawal/
Reduced social interaction 12 (20%) 0 0
Tearfulness 12 (20%) 0 0
Temporal disorientation 16 (25%) 3 (14%) 0
Weight change 25 (40%) 8 (36%) 0
Worry 16 (25%) 2 (9%) 1 (2%)
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In conclusion, the risk of dementia appears different in
DS, WS, and FXS syndromes suggesting that ID and
dementia should be managed as distinct clinical entities.
Unlike general population, people with an ID have under-
gone several psychological assessments including intelli-
gence testing during childhood and adolescence. This
information combined with regular screening for dementia
signs done by close‐care takers followed by neurological
evaluations are the key to appropriate diagnostics and suc-
cessful interventions to improve the quality of life of those
with dementia signs. Further studies are needed to evaluate
the occurrence of dementia in other disorders such as, e.g.,
autism spectrum disorder and cerebral palsy associated IDs,
in order to see whether this same phenomenon does concern
also the other than these three genetic ID syndromes.
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male patients. Clinical Genetics, 89, 55–59. https://doi.org/10.
1111/cge.12639
TABLE 4 Dementia scores according the adolescent severity of
intellectual disability (ID), DS, WS, FXS
Severity of ID
score N Ages or median age
Scores or
median
Subnormal 2 29 (FXS) and 58 (WS) 0 and 5
Levis 27 54 2
Moderate 46 54 3
Severe 50 54 2
Profound 3 50 (DS), 53 (DS) and 61
(FXS)
5, 8 and 1
Note. DS: Down syndrome; FXS: Fragile X syndrome; WS: Williams syndrome.
TABLE 3 State of health of the study subjects
Down Williams Fragile X
No health problem 8 (13%) 0 3 (7%)
Neurological comorbidity
Alzheimer disease* 14 (23%) 0 0
Epilepsy 15 (24%) 3 (14%) 12 (27%)
Vascular dementia, moyamoya* 1 (2%) 3 (14%) 0
Transient ischemic attacks 0 5 (23%) 1 (2%)
Sleep apnea 1 (2%) 2 (9%) 0
Migraine 0 3 (14%) 0
Movement disorder 1 (2%) 6 (27%) 0
Gastrointestinal comorbidity
Diverticulitis 0 8 (36%) 0
Coelicia 1 (2%) 2 (9%) 0
Reflux 1 (2%) 6 (27%) 0
Constipation 5 (8%) 5 (23%) 0
Rectal prolapse 0 7 (32%) 1 (2%)
Hirschprung disease, stoma 1 (2%) 0 0
Cardiovascular comorbidity
Congenital heart defect 7 (11%) 10 (45%) 1 (2%)
Hypertension 0 17 (77%) 2 (4.5%)
Autoimmune disease
Diabetes type 1 or 2 3 (5%) 7 (32%) 3 (7%)
Hypothyroidism 31 (50%) 6 (27%) 4 (9%)
Pemphigoid 0 0 1 (2%)
Rheumatoid arthritis 0 2 (9%) 0
Psychiatric disorder 1 (2%) 11 (50%) 5 (11%)
Sensory impairment
Visual impairment 1 (2.5%) 8 (13%) 2 (4.5%)
Cataracta 7 (11%) 3 (7%)
Chronic infection
Skin infection 0 0 2 (4.5%)
Urinary infection 4 (6%) 2 (9%) 0
Skeletal impairment
Scoliosis/kyphosis 1 (2.5%) 11 (38) 5 (11%)
Joint luxations 3 (5%) 2 (7) 0
Craniosynostosis‐cleft palate 0 1 (4.5%) 0
Other
Hypercholesterolemia 4 (10%) 9 (41%) 2 (4.5%)
Gout 2 (5%) 0 0
Renal insufficiency 2 (5%) 1 (4.5%) 0
Enlarged prostate 1 (2%) 0 12 (29%)
Psoriasis 2 (5%) 0 0
Cancer 0 2 (9%) 0
Asthma 0 1 (3) 1
Lymphoedema in legs 0 3 (14%) 0
Note. *Confirmed with brain magnetic resonance image, or with brain tomography.
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